Dr Reddy's Laboratories Q1 result: Net profit dips 0.90%, revenue up 13.88%
DRL's growth was primarily driven by the robust performance of the global generics business, particularly in North America and India
DRL's growth was primarily driven by the robust performance of the global generics business, particularly in North America and India